3D Printing Technology in Pharmaceutical Dosage Forms: Advantages and Challenges.

3D Printing fused deposition molding inkjet printing personalized medication photo-polymerization. stereolithography

Journal

Current drug targets
ISSN: 1873-5592
Titre abrégé: Curr Drug Targets
Pays: United Arab Emirates
ID NLM: 100960531

Informations de publication

Date de publication:
2021
Historique:
received: 25 09 2020
revised: 14 12 2020
accepted: 20 12 2020
pubmed: 27 1 2021
medline: 3 2 2022
entrez: 26 1 2021
Statut: ppublish

Résumé

Three Dimensional (3D) printing is a promising method for quick prototyping and manufacturing of any material. It is similar to photocopy or printing, where the new materials are formed on layers (3D) like their mother component. Following its growth and advancement in the 1980s, its application in pharmaceuticals is still limited. It has become one of the most innovative and influential tools serving as a technology for developing dosage forms from the last decade. The potential of 3D printing to produce drugs for precise measurement customized to specific patients' needs has shown the possibility of developing personalized medicines to novel dosage forms. The breakthrough allows the clear perception of the dosage structures on different shapes, sizes, surfaces and the associated challenges in delivering them by using such designed conditions. There are different difficulties related to the correct utilization of 3D imprinting in the pharmaceuticals, which have a strong impact on the scope of this technology. Recent advancements in the field of 3D printing technology used in the pharmaceutical industry mainly focused on different techniques for the fabrication of different dosage forms. The Food and Drug Administration's (FDA) recent approval of the first 3D prescription highlights possibilities for 3D printing innovation in the field of pharmaceutical drug supply. This analysis assesses 3D printing advancement possibilities, particularly in the area of custom prescriptions. This technology can be regarded as the future produced on demand, low-cost solid dosage forms and helps minimize side effects due to overdose.

Identifiants

pubmed: 33494666
pii: CDT-EPUB-113480
doi: 10.2174/1389450122666210120142416
doi:

Substances chimiques

Dosage Forms 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1901-1914

Informations de copyright

Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Auteurs

Prasanna Kumar Desu (PK)

K L College of Pharmacy, Koneru Lakshmaiah Education Foundation, Vaddeswaram, Andhra Pradesh, India.

Balaji Maddiboyina (B)

Department of Pharmacy, NRK & KSR Gupta College of Pharmacy, Tenali, Guntur, Andhra Pradesh, India.

Kondi Vanitha (K)

Department of Pharmacy, Vishnu Institute of Pharmaceutical Education and Research, Narsapur, Medak, Telangana, India.

Shiva Naga Koteswara Rao Gudhanti (SNK)

K L College of Pharmacy, Koneru Lakshmaiah Education Foundation, Vaddeswaram, Andhra Pradesh, India.

Rapuri Anusha (R)

Department of Pharmacy Practice, Nirmala College of Pharmacy, Mangalagiri, Guntur, Andhra Pradesh, India.

Vikas Jhawat (V)

Department of Pharmacy, School of Medical & Allied Sciences, GD Goenka University, Gurgaon, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH